AN2 Therapeutics, Inc (NASDAQ:ANTX) IPO will take place March, 25 on the NASDAQ exchange under the ticker ANTX.
The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on September 21, 2022.
See also: Benzinga IPO Calendar
About AN2 Therapeutics, Inc
AN2 Therapeutics, Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs
See also: Benzinga’s Most Shorted Stocks
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
